Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model. The Dow Jones Industrial Average ( ^DJI) is trading down 99.0 points (-0.6%) at 15,310 as of Wednesday, May 29, 2013, 1:35 p.m. ET. During this time, 341.5 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 594.8 million. The NYSE advances/declines ratio sits at 482 issues advancing vs. 2,555 declining with 59 unchanged.
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
The Dow component leading the way higher looks to be Travelers Companies (NYSE: TRV), which is sporting a 26-cent gain (+0.3%) bringing the stock to $83.48. Volume for Travelers Companies currently sits at 1.5 million shares traded vs. an average daily trading volume of 1.9 million shares. Travelers Companies has a market cap of $31.47 billion and is part of the financial sector and insurance industry. Shares are up 15.9% year to date as of Tuesday's close. The stock's dividend yield sits at 2.4%. The Travelers Companies, Inc., through its subsidiaries, provides various commercial and personal property and casualty insurance products and services to businesses, government units, associations, and individuals primarily in the United States. The company has a P/E ratio of 12.6, below the S&P 500 P/E ratio of 17.7. TheStreet Ratings rates Travelers Companies as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, increase in net income, notable return on equity, attractive valuation levels and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.